Champlain Investment Partners, LLC
Q2 2021 13F-HR Holdings
Net value change ($000)
+1,816,848
(9.5%)
New positions
8
Sold out positions
5
Turnover %
6.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| STE | 347,706 | NEW |
| ASAN | 256,580 | 178.0% |
| Anaplan, Inc. | 131,840 | NEW |
| GNRC | 98,270 | 44.1% |
| MRVI | 83,287 | 136.7% |
| CSGP | 82,373 | NEW |
| Medallia, Inc. | 77,277 | 20.9% |
| LESL | 75,578 | 112.9% |
| OKTA | 69,136 | 47.8% |
| WAT | 68,759 | 24.5% |
Top Reduces (Value $000, Stocks/ETFs)
| CANTEL MEDICAL LLC | -319,813 | -100.0% |
| PROOFPOINT INC | -182,886 | -100.0% |
| CPB | -135,059 | -100.0% |
| THS | -48,832 | -32.8% |
| NVST | -45,537 | -56.8% |
| ULTA | -41,919 | -20.2% |
| TSCO | -40,011 | -15.2% |
| BGS | -38,741 | -100.0% |
| AVNS | -32,561 | -25.6% |
| CFR | -23,441 | -13.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|